The newly synthetized pyridobenzoxazocynone inhibits HIV-1 reverse transcriptase activity

Farmaco. 1997 Dec;52(12):751-3.

Abstract

We synthetized pyridobenzoxazocynone that differs in the enlarged eight-membered heterocyclic system from the basic structure of pyridobenzoxazepinones a known class of non-nucleoside HIV-1 reverse transcriptase inhibitors. Pyridobenzoxazocynone hydrochloride was found to inhibit HIV-1 reverse transcriptase activity. At concentration 0.35 microM the enzyme activity decreased by 64 +/- 14%. Higher concentrations of pyridobenzoxazocynone hydrochloride completely abolished the enzyme activity expressed as radioactivity of acid insoluble products. These results suggest that pyridobenzoxazocynones may represent a new class of HIV-1 reverse transcriptase inhibitors.

MeSH terms

  • Gene Products, pol / antagonists & inhibitors
  • HIV Reverse Transcriptase / antagonists & inhibitors*
  • Humans
  • Molecular Structure
  • Oxazocines / chemical synthesis*
  • Oxazocines / pharmacology
  • Pyridines / chemical synthesis*
  • Pyridines / pharmacology
  • Reverse Transcriptase Inhibitors / chemical synthesis*
  • Reverse Transcriptase Inhibitors / pharmacology

Substances

  • Gene Products, pol
  • Oxazocines
  • P protein, Hepatitis B virus
  • Pyridines
  • Reverse Transcriptase Inhibitors
  • pyridobenzo(b,f)1,5-oxazocyn-6-one
  • HIV Reverse Transcriptase